Blueprint Medicines was founded in 2011 and is headquartered in Cambridge, Massachusetts. This precision therapy company is focused on genomically defined cancers, rare diseases and cancer immunotherapy. It develops medicines based on protein kinases, which are enzymes that modify the functions of proteins... Show More
Seems to be good reason for a trade in the opposite. Btoh technically with support levels and fundamentally with FDA Phase 2 data on 11th April. Seems like good reward/risk ratios for a short term trade. ... Show More